Decoding Alzheimer’s and Aging With Proteomics
Discovering novel biomarkers in cellular aging research via mice and Alzheimer’s disease studies.
Biofluids are reservoirs of untapped knowledge that harbor a trove of protein biomarkers, yet their complexities impede deep exploration.
In this webinar, learn how the transformative power of cutting-edge, unbiased proteomics, harnessed by Seer’s Proteograph™ workflow, is helping breakthrough study depth challenges and reshape the realms of cellular aging and Alzheimer’s disease research.
We unveil groundbreaking insights from a study on Alzheimer’s disease progression, highlighting how the Proteograph XT is shedding new light on pathophysiological pathways, biomarkers, and early detection potential.
This webinar is best for:
- Proteomics and genomics research professionals.
- Scientists focused on the study of biofluids and neurology.
- General scientific community.
Things you’ll learn about:
- Seer’s and National Institute on Aging’s (NIA) unique methods using deep, unbiased proteomics workflows with the Proteograph for biomarker detection.
- NIA’s study profiling with minimal serum volume in mouse models to uncover cellular senescence protein signatures and decode the secrets of aging.
- An 1,800-sample study of AD progression and the novel discoveries made.
Featured Speakers
Nate Basisty, Ph.D. NIH Distinguished Scholar, National Institute on Aging (NIA)
Asim Siddiqui, Ph.D. SVP, Research and Tech Development, Seer Inc.
Watch Webinar On-Demand
Fill out the form to watch the webinar.